abstract |
It is intended to provide a humanized anti-human osteopontin antibody which is superior to conventional anti-human osteopontin antibodies in terms of activities (an antigen-binding activity, a leukocyte migration inhibitory activity and the like) and/or stability (resistance to heat, hypoxic conditions or denaturants, and the like). |